Preamble
Biomedical research has a need to use nonhuman primates in cases where no other species offer the specific scientific information required or the necessary predictability of results for the development of medicines and vaccines. Biomedical research institutions would prefer purpose-bred animals of known history with an amount of background information necessary for an unbiased interpretation of findings from animal experiments. It is also anticipated that the microbiological status of such animals is easier to define and to control and better than that of animals from other sources.
Due to the difficulty in predicting requirements and the high investment costs of setting up colonies especially with breeders born in captivity, the breeding establishments existing at present have not yet established sufficiently large breeding colonies, especially with captive-born breeders, to fulfil the requirements of biomedical research for purpose-bred animals of all of the commonly used species. However, even animals from other sources should be delivered with a report on the health status after a quarantine period at the supplier institution. Good Laboratory Practice requires that sufficient background information is available to allow for accurate interpretation of findings from animal experiments. This means that besides endeavouring to rid breeding colonies of unwanted agents, regular monitoring and honest reporting of the findings is imperative. Moreover, a reliable health monitoring programme at the supplier's centre usually allows clients to shorten the quarantine procedures that are prescribed by national authorities in the countries of destination. A certification of the health status of nonhuman primates should also accompany all primate shipments from suppliers to research institutions or between these institutions. Individual lifetime records should, besides mentioning any periods of illness, test results of individual samples and vaccinations, be accompanied by a health status certification of the colony from which it originates and other colonies in which it was kept.
At present no single recognized health control programme exists for laboratory primates. The requirements outlined in these recommendations are intended to harmonize existing protocols. They may be subject to remodelling due to the emergence of possible new pathogens as well as to developments in the use of non-human primates in biomedical research, chiefly in view of transplantation studies. Many, if not the majority, of the available purpose-bred animals of the larger non-human primate species still belong to the FI generation of parents captured in the wild. These are potential carriers of microbiological agents endemic in the wild population. In view of the longevity of primates, 51:4 problems with the breeding performance of animals born and reared in captivity, and the high demand for purpose-bred animals, this situation will continue for some years. According to those tests which have already been performed on request, some breeding colonies are free of certain, but usually not all of the microbiological agents potentially interfering with biomedical research data or transmissible to humans. Besides, monkeys are often susceptible to the same agents as humans and, therefore, may acquire some that are not present in their natural environment through close contact with humans. Health monitoring of the animal care staff is essential both for the protection of the staff itself, as well as to avoid introducing disease agents.
The recommendations are directed to breeders, other suppliers and users holding non-human primate colonies for prolonged periods of time. It is concerned with the most commonly used species in Europe. These are: It was not considered necessary to include apes, since these are used in Europe only at two specialized institutes having their own specific health control requirements.
Certification of health status of animals by the supplier
Though it would be desirable to gradually obtain non-human primates free of pathogens, it must be realized that, unlike rodents, such animals are at present not available in sufficient numbers. The main aim of these recommendations are, however, to encourage suppliers to provide the users with all the information that is important for the interpretation of their experimental results and for working safely with the animals received.
Breeding establishments should be able to control and document the health status of their colonies and the animals supplied. This involves thorough clinical ot pathological examinations of individual animals and the use of regular appropriate laboratory tests of the population maintained in the same unit. Animals from sources other than closed breeding colonies should be kept under quarantine at the supplier centre and undergo the same examinations for the presence of disease before delivery.
Single negative laboratory tests obtained shortly before shipment are only of relevance if the animals have been prevented from contact with potentially infected animals (or humans) for the incubation period of the disease. If this is not the case it would be more informative to know the incidence of positive animals within the group or unit in which the monkeys were kept. A 'unit' is defined as a self-contained microbiological entity. As a rule all individuals of a unit with seropositive animals, or animals showing other evidence of infection should be considered as potential carriers of the infectious agent if not otherwise proven.
List of pathogenic and other undesirable microbiological agents
In Tables 1 and 2 of the appendix a list of microorganisms and parasites is provided which is chiefly based on current concern, on the health risk for personnel handling the animals, and the frequency with which the agents are found in laboratories using nonhuman primates. Other criteria for inclusion were infections that may spread in a colony without or prior to clinical symptoms, and could cause disease in more susceptible species or immune-deficient animals. Beside those agents included in Tables 1 and 2 of the appendix, non-human primates are known to harbour a number of further microorganisms and parasites that may be pathogenic or interfere with experiments. Of those not considered in the tables Yersinia pestis, that is known to be endemic in the rat population in certain regions, and Bordetella spp., Helicobacter pylori, Klebsiella, Pseudomonas aeruginosa as ubiquitous microorganisms as FELA5A Working Group on Non-Human Primate Health well as Filaria spp. that have occasionally been found in groups of New World primates may turn out to be important in the future.
Not much is known of the influence of inapparent infections on the experimental results, but where this is the case it is mentioned in Table 1 and the agent has been included in the tables even though an infection may have no known clinical importance for the animals themselves or humans.
Based on current concern in view of transmission to humans and frequency of findings, a reduced list of microbiological agents and parasites for which testing is considered as mandatory is presented for the primate groups from the three areas of Africa, Asia and South America. For most of the agents in the following three lists monitoring is commonly requested. However, any other agent, including those mentioned in Tables 1  and 2 .should be reported in health certificates when found to be present or identified as cause of a disease outbreak. It is advised that initially or after changes of the colony composition a complete microbiological profile of the non-human primate colony be established. The term 'initially' refers to the start of a new unit, commencement of a diagnostic test programlne in an established unit, after a disease eradication programme or during quarantine of non-human primates intended for biomedical research. For primate colonies already committed to a health control programme, the initial more frequent testing for the declaration of absence of an infectious agent is not necessary, provided three consecutive tests at one-year intervals within the preceding two years were negative.
Macaques
Once the microbiological status has been defined, the requirement for inclusion in a regular testing programme only applies to those agents for which there is a risk of introduction and spread within the colony or unit. A colony or unit may, however, only be declared free of a certain agent if it has 51:6 been tested for the corresponding agent according to Table 2 . For diseases declared to be absent in the region of the non-human primate colony by a competent national authority no monitoring for that specified agent is needed. The same may apply to a colony into which no new animals are introduced provided it is housed in units for which an infection by a specific agent can be excluded due to its closed construction.
Periodical testing is also not necessaryexcept for scientific or epidemiological reasons-if laboratory test results or overt clinical disease indicate that the colony harbours a certain microorganism or parasite and if no measures have been taken to eliminate it. In the latter case the presence of the agent has to be mentioned in all subsequent health reports until an attempt to eradicate it has been undertaken.
While it will reveal the efficiency of the vaccination scheme, antibody testing of vaccinated animals is also not necessary for the health monitoring report. The vaccination, however, has to be mentioned in the certificate, and is no proof of absence for that particular agent.
Monitoring procedures, sampling and sample sizes
The test methods mentioned in Table 2 reflect currently applied techniques used in the relevant publications and by the existing specialized diagnostic laboratories. In general the most appropriate and updated method should be used. No attempt has been made to suggest the use of a specific method, but by experience of members of the group, for some microorganisms the results may differ between the diagnostic laboratories and the test methods applied. It is, therefore, absolutely necessary to mention the applied method and the testing laboratory in the report. Improvement of the reliability of the diagnostic tests is highly desirable.
The minimal number of samples (serum, faeces) for screening colonies or units shall be 10. These samples should be gathered randomly for each 'unit' (understood as selfcontained microbiological entity) from indi-Laboratory Animals (1999) 33 (Suppl. 1) FELASA Working Group on Non-Human Primate Health vidual animals. They should not be pooled. Theoretically this sample size will detect an infection incidence of 25-30% in the unit with a probability of 95%. Negative results in single tests only mean that those animals selected for screening had not developed antibodies or were not shedding bacteria or parasites at the time the samples were taken. Equivocal or unexpected test results should be confirmed by repeating the test with the same animal and possibly using another diagnostic method. On the other hand in periodical standard investigations different animals should be used in succeeding tests.
All samples should be taken from live animals or at least within a few hours after the death of the animals. However, the identification of any pathogenic agent in organic material at even a later stage is regarded as proof for the presence of this agent within the colony.
Serum samples for antibody testing should preferably be obtained from animals over one year in age whereas faecal samples for the detection of bacteria and parasites are often more informative when taken from juvenile animals or at weaning and on three consecutive days.
Some clients require tests to be performed on each individual animal before shipment. In the future this may also be a requirement of national veterinary offices. It is considered as good practice to inspect each outgoing animal before shipment. Taking the required number of 10 animals per unit annually into account, the results of these examinations may, of course, and should be used for the health monitoring report on the unit from which the animals for exportation were selected.
Additional or intermediate tests to those listed above may be required for the diagnosis in animals with clinical signs of disease or on request of clients for the clarification of unexpected results. It is also reasonable to perform a full necropsy of all dead animals from a unit and include the findings in the health monitoring programme and reports. Such findings as well as those obtained from routine clinical inspection (e,g. ectoparasites) may help reduce the costs for standard periodic investigations. For some parasites (e.g. lung mites and Filaria spp.)necropsies are the only reliable diagnostic method.
For the shipment of serum samples to diagnostic laboratories it may be requested to inactivate the serum to reduce the risk of human infection. Methods recommended are heat inactivation (56°C for 30 min) or addition of merthiolate to the serum (1:10).All sample vials must be shipped leak-and break-proof.
Some countries require a CITES certification for the import of serum from nonhuman primates. Since the regulations for the import and transport of biologicals vary from one nation to the other and may occasionally be modified} it is recommended to obtain the necessary instructions from the testing laboratory well in advance of the shipment.
Eradication and treatment: declaration of freedom of specified agents
The eradication possibilities referred to in Table 2 should be considered as suggestions. Experience gained with attempts to obtain pathogen-free colonies are scarce at present.
Methods used for other laboratory animals (Caesarean section} embryo transfer) are hardly feasible for non-human primates for obvious reasons. Even hand-rearing of newborn animals could lead to behavioural problems when they are to be used as founders of breeding colonies.
Where therapeutics are available this is indicated in Table 1 . Antibiotic treatment is} however} not always reliable for complete elimination of microbes. For some diseases no effective treatment is known. In such cases separation of infected from noninfected animals and initial frequent testing of the latter (if necessary during a quarantine period in individual cages) may be the only solution for eliminating pathogenic agents from colonies or units.
Vaccination may in some cases beacceptable as protective measure for animal groups if free of the corresponding microorganism and when the risk of re-infection is otherwise unavoidable. However} the differentiation between vaccinated and naturally infected 51:7 animals could cause problems. Vaccination may also not be advisable for animals to be used in immunological studies.
The elimination of many of the agents listed in the attached Tables 1 and 2 from monkey colonies may only be achieved in stages. Nevertheless} consideration should be given from the onset about precautions against the spread of these agents within the colonies and introduction by wild mammals, birds, insects, man and materials. Such measures may include fences or walls with electrical wiring around the compounds, entry locks with disinfectants and spacing the individual enclosures or units sufficiently far apart to avoid cross contamination. Within the compounds or units rodent and insect traps could be used to eliminate possible vectors. A plan for the disinfection of material that could be exchanged between units as well for the periodical disinfection of enclosures should be established. Attention should be paid to the construction of the waste-water system as a possible source of cross-contamination.
Health monitoring report
A major purpose of health monitoring of animals of breeding and other supplier establishments or in experimental units is to provide the user with data on variables that might influence the outcome of the experiment. These data are part of the experiment and have to be considered during the interpretation of the results by the investigator and by the reader of a publication. Authors of scientific articles should, therefore}be able to provide the information on the health status of their animals used on request.
For non-human primates that may harbour disease agents transmissible to man, monitoring and reporting the health status of the animals is also essential for protective measures to be taken on behalf of personnel handling the animals at the breeding site, during transport and at the research centre.
The health monitoring certificate of a nonhuman primate facility should include the following information:
(1) Species, breed, and unit for which the report is valid.
(2) Date of colony/unit establishment or restocking or re-derivation. As an example for a health report for primate units in accordance with FELASA recommendations a specimen sample form for macaques is added as an appendix. Reports concerning other species should be adapted according to the lists in Parts 3.1 to 3.3 of this Report.
Final remarks
While it is clear that FELASAcannot accept responsibility for tests and their implications, breeders or users of laboratory animals who are reporting on the health status of their animals may use the wording 'in accordance with FELASArecommendations' under the following conditions:
• The microorganisms monitored correspond with those listed as mandatory in this recommendation. Additional patho- FELASAis aware of the fact that following these recommendations will increase the costs for supplying non-human primates. It has, therefore, been the aim of the Working Group to recommend only a minimal frequency of testing by defining the conditions under which further testing of certain microorganisms need not be performed, and allowing for the inclusion of results from other investigations (e.g. for the shipment of animals) in the standard monitoring system. Experience shows that results obtained from different diagnostic laboratories may vary considerably depending on the methods used. Aims to standardize or correlate the methods applied by use of reference laboratories should be encouraged.
Improving the health status of non-human primate colonies will take some time. It is, therefore, at present not possible to exclude animals with potential pathogens completely from research. Nevertheless, regular control and reporting of the health status are basic requirements for the characterization of animals used in research.
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